Recce Pharmaceuticals is an Australian biopharmaceutical company that develops synthetic anti-infective drugs. Its filings show it lobbied U.S. policymakers on health issues, specifically the development of anti-infectives for treating burns in military settings. It has worked with the U.S. firm Horizons Global Solutions and reported $92,000 in lobbying across six filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JULIE LASSETER
The latest disclosures for this client.
HORIZONS GLOBAL SOLUTIONS LLC
Q3YHORIZONS GLOBAL SOLUTIONS LLC
Q2YHORIZONS GLOBAL SOLUTIONS LLC
The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
HORIZONS GLOBAL SOLUTIONS LLC
mr STEPHEN ELLIOTT BOYD
HORIZONS GLOBAL SOLUTIONS LLC
mr DAVID FORREST LASSETER
HORIZONS GLOBAL SOLUTIONS LLC
HORIZONS GLOBAL SOLUTIONS LLC
4AHORIZONS GLOBAL SOLUTIONS LLC
4AHORIZONS GLOBAL SOLUTIONS LLC
Q4HORIZONS GLOBAL SOLUTIONS LLC
Q3HORIZONS GLOBAL SOLUTIONS LLC
Q2HORIZONS GLOBAL SOLUTIONS LLC
Q1Y